Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020416 · ClinicalTrials.gov registry record · Phase 1
AutoSTEA for Adults With Functional Dyspepsia
A Phase 1 study of Functional Dyspepsia, sponsored by MetroHealth Medical Center.
- Active
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT07020416 is a Phase 1 study of Functional Dyspepsia that is active but no longer recruiting, run by MetroHealth Medical Center. The registered enrollment target is 20 participants, below the 71-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07020416, a Phase 1 study of Functional Dyspepsia, is active but no longer recruiting, sponsored by MetroHealth Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to assess how effective the AutoSTEA device is in treating functional dyspepsia (upper abdominal discomfort) in adults. It will also assess the safety and usability of the device. The main questions it aims to answer are: * Does the AutoSTEA device ease dyspepsia symptoms? * Is the AutoSTEA device safe and feasible for patients to use at their home? Participants will: * Use the device for half an hour every day for two weeks * Have a phone check-in halfway through the trial * Answer the daily and weekly questionnaires which consist of questions regarding symptoms, device usability, and adverse events experienced.
Conditions Studied
Interventions
- DEVICE Transcutaneous electrical acustimulation in automatic synchronization with breathing
Study Locations (2)
Ohio
- MetroHealth Medical Center - Main Campus - Cleveland
- MetroHealth Parma Medical Center - Parma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2027-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07020416
The ClinicalTrials.gov registry entry for NCT07020416 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 71-participant average among 9 other Functional Dyspepsia trials with a reported enrollment target (72% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Functional Dyspepsia appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous electrical acustimulation in automatic synchronization with breathing is the first listed.
NCT07020416 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07020416 about?
NCT07020416 is a clinical study titled "AutoSTEA for Adults With Functional Dyspepsia". The goal of this study is to assess how effective the AutoSTEA device is in treating functional dyspepsia (upper abdominal discomfort) in adults. It will also assess the safety and usability of the device. The main questions it aims to answer are: * Does the AutoSTEA device ease dyspepsia symptoms?...
What is the current status of trial NCT07020416?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2025-02-26. Estimated completion is 2027-02.
What conditions does trial NCT07020416 study?
This clinical trial studies the following conditions: Functional Dyspepsia.
What interventions are being tested in trial NCT07020416?
The interventions under investigation include: Transcutaneous electrical acustimulation in automatic synchronization with breathing (DEVICE).
Who is sponsoring clinical trial NCT07020416?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020416 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Functional Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
RECRUITING · NA
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Ketotifen for Children With Functional Dyspepsia in Association With Duodenal Eosinophilia
RECRUITING · Phase 3
-
Autonomic Reactivity and Personalized Neurostimulation
RECRUITING · NA
-
Functional Dyspepsia Treatment Using Virtual Reality
RECRUITING · NA
-
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.